SCHEMBL4248499

SCHEMBL4248499

CCOP(=O)(OCC)OCc1cccc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.50
AGXT P21549 2/20 0.50
MAOB P27338 11/20 0.48
NR4A2 P43354 1/20 0.46
PARP10 Q53GL7 1/20 0.44
MAOA P21397 2/20 0.42
HCAR2 Q8TDS4 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5167661 0.82 IDO1 (0.51) IDO1MAOBMAOATSHR
SCHEMBL779676 0.81 IDO1 (0.55) IDO1AGXTMAOBNR4A2PARP10
SCHEMBL27632169 0.81 TSHR (0.42) TSHR
SCHEMBL27831115 0.80 IDO1 (0.54) IDO1MAOBNR4A2
SCHEMBL4248141 0.79 IDO1 (0.54) IDO1AGXTMAOB
SCHEMBL743706 0.79 TSHR (0.57) TSHR
SCHEMBL2980165 0.79 TSHR (0.57) TSHR
SCHEMBL29938481 0.79 IDO1 (0.43) IDO1AGXTMAOB
SCHEMBL779677 0.79 MAOB (0.52) IDO1AGXTMAOBNR4A2PARP10
SCHEMBL4542812 0.79 IDO1 (0.43) IDO1AGXTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170901-A1 Benzoyl Urea Derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2009-07-02 US disclosed
EP-1771429-A1 NEW BENZOYL UREA DERIVATIVES RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2007-04-11 EP disclosed
WO-2006010966-A1 NEW BENZOYL UREA DERIVATIVES Richter Gedeon Vegyészeti Gyár Rt. (HU) 2006-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170901-A1 Benzoyl Urea Derivatives OPRM1, GRIN2C, GRIN3A IDO1 2101/4885AGXT 2703/4885MAOB 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.